CD82 (KAI1) is a metastasis suppressor that inhibits tumor progression through multiple mechanisms, including the attenuation of cell motility, maintenance of cellular polarity, and induction of apoptosis in response to extracellular stimuli, while also regulating protein trafficking and membrane dynamics (15, 16). This evidence concerns the gene CD82 and neoplasm.